	Side effects of hormone therapy in patients with malignant breast neoplasm: a cross-sectional study. Rev Bras Enferm de Freitas Corpes E, Yanez RJV, Saraiva Dos Santos CPR, Barbosa MD, da Cruz Alencar MMS, de Almeida PC, Fernandes AFC, Barbosa Castro RCM. PMID: 41370618 [PubMed - indexed for MEDLINE]
	A review on herbal interventions and nanotechnological advancements for managing polycystic ovarian syndrome. JBRA Assist Reprod Sharma K, Bhardwaj S, Nagarajan K. PMID: 41370421 [PubMed - indexed for MEDLINE]
	Prevalence and determinants of precancerous cervical lesions among women screened for cervical cancer in Africa: A systematic review and meta-analysis. PLoS One Mengistie BA, Aragaw GM, Anteneh TA, Wondie KY, Kassie AT, Abuhay AE, Biset WM, Mulatu GG, Tsega NT. PMID: 41370265 [PubMed - indexed for MEDLINE]
	Differences in Clinical Trial Availability vs Distribution of Disease Among Gynecological Cancers. Oncology (Williston Park) Andrea I Nañez Md, Velez MA, Mae Zakhour Md, Garon EB. PMID: 41370239 [PubMed - indexed for MEDLINE]
	Cognitive function during endocrine treatment with or without cyclin-dependent kinase 4/6 inhibitors for advanced breast cancer. Cancer Luijendijk MJ, Lee Meeuw Kjoe PR, Wortelboer N, van Ommen-Nijhof A, van Leeuwen-Stok AE, Agelink van Rentergem JA, Vermeulen IE, Konings IR, Jager A, Sonke GS, van der Wall E, Schagen SB. PMID: 41370190 [PubMed - indexed for MEDLINE]
	Breast Cancer Progression by the FGF/FGFR Axis: A Metabolic Perspective. J Mammary Gland Biol Neoplasia Tuokkola JE, Schwertfeger KL. PMID: 41369841 [PubMed - as supplied by publisher]
	HER2CLIMB-05: A Phase 3 Study of Tucatinib Versus Placebo in Combination with Trastuzumab and Pertuzumab as First-line Maintenance Therapy for HER2+ Metastatic Breast Cancer. J Clin Oncol Dieras V, Curigliano G, Martin M, Lerebours F, Tsurutani J, Savard MF, Jerzak KJ, Hu X, Martins de Aquino Pimentel LC, O'Sullivan CC, Tokunaga E, Okines A, Huang CS, Jacot W, Sohn J, Cronemberger Silva E, Mueller V, Yang S, Granata G, Shen Q, Santarpia L, Hamilton E. PMID: 41369677 [PubMed - as supplied by publisher]
	Antiandrogens and insulin sensitizers in PCOS management. Minerva Obstet Gynecol Lello S, Fagotti A, Colonna L, DI Lella G, Vignali M, Capozzi A. PMID: 41369212 [PubMed - indexed for MEDLINE]
	Defining the optimal Ki67 cutoff values for survival prediction in neoadjuvant chemotherapy-treated patients with breast cancer. Front Surg Jiang C, Zhu T, Zong Y, Liu R, Du J, Dai J, Song Y, Zhang D, Wang X, Shi Z, Jiang Y, Bu J, Ding B, Zhu X. PMID: 41368527 [PubMed]
	Systemic and locoregional therapies for cutaneous metastases from breast cancer: state of art and new frontiers in treatment approach. Ther Adv Med Oncol Russano F, Brugnolo D, Bottosso M, Dall'Olmo L, Del Fiore P, Baldan R, Ferrucci M, Musilli N, Vittoria Dieci M, Guarneri V, Rastrelli M, Mocellin S. PMID: 41367954 [PubMed]
	Cervical Cancer in Women With HIV: A Call to Action for Equitable Prevention in Low- and Middle-Income Countries. Biomed Res Int Klutse J, Tay YA, Attoh DA, Gyekye EF, Bortey CB, Buatsi ED, Oppong CC, Lamptey H, Ahorlu CS, Kyei GB, Bonney EY. PMID: 41367932 [PubMed - indexed for MEDLINE]
	Effect of vitamin D deficiency on clinical pregnancy outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization. Front Endocrinol (Lausanne) Yu L, Hu B, Kong J, Xu X, Zhang C. PMID: 41367918 [PubMed - indexed for MEDLINE]
	Drug-induced polycystic ovary syndrome: a real-world pharmacovigilance study based on the FAERS database. Front Endocrinol (Lausanne) Zhang H, Di M, Wang Y, Ma Y, Gou Y, Zhou Z. PMID: 41367917 [PubMed - indexed for MEDLINE]
	Research on breast tumor segmentation based on the Mamba architecture. Front Oncol Wei W, Wu J, Shao G. PMID: 41367863 [PubMed]
	Management of ovarian granulosa cell tumor in childhood: a case report and recommendations for a multidisciplinary approach. Front Oncol Arnaboldi SMC, Gattuso G, Nicolosi ML, Molinari S, Bettini LR, Leva E, Passoni P, Chiappa V, Daolio C, Balduzzi AC, Massimino M, Terenziani M, Cattoni A. PMID: 41367860 [PubMed]
	Percentage apparent diffusion coefficient change for early prediction of response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis, and a retrospective study. Quant Imaging Med Surg Ren A, Liu J, Li Y, Tang Z, Li Y, Wang R, Hu Q, Zhang X, Yang W, Huang T, Yang F, Ming J. PMID: 41367736 [PubMed]
	Improving Efficiency in Dutch Cervical Screening by Genotyping: An Analysis of Real World Program Data. J Med Virol Olthof EMG, van den Brule AJC, Melchers WJG, Berkhof J, de Kok IMCM. PMID: 41367324 [PubMed - indexed for MEDLINE]
	MAGE-A in triple-negative breast cancer: molecular biology, epigenetic targeting, and immunotherapy. Epigenomics Nik Amirah Auni NMA, Mohd Redzwan N, Hussain FA, Yahya MM, Wong KK. PMID: 41367288 [PubMed - as supplied by publisher]
	Discovery and targeted Mass spectrometry-based proteomics of Ovarian cancer. Expert Rev Proteomics Platzer NE, Hummon AB. PMID: 41367230 [PubMed - as supplied by publisher]
	Identification of an oxidative stress-related prognostic signature, tumor immune microenvironment, and development of subtypes for breast cancer patients receiving neoadjuvant chemotherapy. Medicine (Baltimore) Shi Z, Shen X, Mao Z, Hang X. PMID: 41367017 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 321586

Page 1 of 16080



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy